Vittoria Biotherapeutics, Inc., a clinical-stage immunotherapy company pioneering innovative cell therapies, today announced ...

Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meetingData from ALLOHA™ Phase 1 heme trial to ...

Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101Dosed first solid tumor patients with multiplex ...

TScan Therapeutics reaches agreement with US FDA on pivotal study design for TSC-101 and announces strategic prioritization to advance TSC-101: Waltham, Massachusetts Wednesday, N ...

Radiant Biotherapeutics to present new data from lead oncology programme at SITC 2025 annual meeting: Toronto Thursday, November 6, 2025, 18:00 Hrs [IST] Radiant Biotherapeutics, ...

Enterprise architect and innovator Prince Kumar bridges AI-driven data governance with patented predictive healthcare systems, creating a new paradigm for proactive pandemic prevention and global ...

-- RBT-101, Radiant's lead oncology program and 4-1BB agonist, demonstrated robust, durable and complete tumor regression without liver toxicity in MC38 colorectal mouse tumor model -- Poster ...

Representatives from Minnesota’s colleges and universities shared with Minnesota senators on Thursday some of the funding ...

Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) ("Liberty Gold” or the "Company”) is pleased to announce the formal commencement of Feasibility Study ("FS”) engineering for its flagship Black Pine Oxide ...

Zavation Medical Products, LLC ("Zavation"), a leading innovator in spinal device technology, proudly announces the launch of NanoPrime(TM) , a next-generation implant material that combines the ...

After years of dispute with FEMA, Sonoma County has completed a new flood study for the Todd Creek watershed that reclassifies nearly one-third of affected parcels — many downgraded from flood ...